Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISPERIDONE vs RITUXIMAB-ABBS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISPERIDONE vs RITUXIMAB-ABBS: Safety Overview

Metric RISPERIDONE RITUXIMAB-ABBS
Total FAERS Reports 79,288 4,347
Deaths Reported 4,120 432
Death Rate 5.2% 9.9%
Hospitalizations 18,771 1,087
Average Patient Age 31.9 yrs 53.5 yrs
% Female Patients 15.6% 74.2%
FDA Approval Date Apr 12, 2007 N/A
Manufacturer NuCare Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Prescription